TAO Synergies TAOX
NASDAQ TAOX
$4.41 +0.02 (+0.46%)
At close: Oct 2, 2026 · 4:00 PM EDT

TAO Synergies (TAOX) Return on Sales [ROS] (2025 - 2026)

Updated

TAO Synergies' Return on Sales [ROS] was -1770.63% in Q2 2026, up 74853.12 percentage points from -76623.75% a year earlier but down 1431.67 percentage points from the prior quarter.

Analysis

TAO Synergies (TAOX) Return on Sales [ROS] (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, TAO Synergies' Return on Sales [ROS] was -1013.48% through Jun 30, 2026; for FY2025, it came in at -3025.19%.

  • Quarterly Return on Sales [ROS] has moved between -76623.75% (Q2 2025) and -338.95% (Q1 2026) over five years.
  • Per Business Quant data, TAOX's Return on Sales [ROS] in the three quarters before Q2 2026 was -338.95% (Q1 2026), -3426.06% (Q4 2025) and -884.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 TAO Synergies 32.96 Mn 32.96 Mn - -1,770.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,770.63%
Mar 31, 2026 -338.95%
Dec 31, 2025 -3,426.06%
Sep 30, 2025 -884.84%
Jun 30, 2025 -76,623.75%
API Access

TAO Synergies Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TAOX&period=max&api_key=YOUR_API_KEY